Delivery Order SPE2DB22D1106-SPE2DB24FEXL7

Award Date 6/17/24
Potential Completion Date 7/10/24
Potential Value $19K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the VARIVAX vaccine with diluents. The contract has a ceiling value of $9,559.70 and is a Delivery Order with a Firm Fixed Price pricing type. The ultimate completion date is May 6, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999.00 through...
This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp is for the delivery of VARIVAX vaccine with diluents. The fixed-price, firm-fixed-price delivery order has a total ceiling value of $18,822.80 and an ultimate completion date of June 7, 2023. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a...
This federal contract award was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of VARIVAX vaccine with diluents, with a ceiling value of $2,867.91 and an ultimate completion date of June 11, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at up to $999,999,999.00 through December 31, 2025....
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of VARIVAX vaccine with diluents to the Defense Logistics Agency (DLA). The contract has a ceiling value of $2,811.03 and a completion date of July 17, 2024. It is a firm-fixed-price delivery order contract, with no set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of VARIVAX vaccine with diluents to the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, on June 27, 2024 with a ceiling value of $125,559.34. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued up to $999,999,999.00 through December...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of the VARIVAX vaccine with diluents to the Defense Logistics Agency (DLA). The contract is a firm fixed price delivery order with a ceiling value of $1,911.94 and a performance period through April 11, 2024. Amerisourcebergen Drug Corp serves as the prime contractor on this award, which is not designated as a set-aside contract. The company also holds an Indefinite...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the supply of VARIVAX vaccine with diluents. The contract has a ceiling value of $2,064.22 and is a firm fixed-price delivery order with a period of performance through February 19, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of VARIVAX vaccine with diluents to the U.S. government. The contract has a ceiling value of $1,911.94 and an ultimate completion date of June 5, 2024. It was awarded by the Defense Logistics Agency (DLA), a defense agency, on a firm fixed-price basis. The award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of VARIVAX vaccine with diluents. The contract has a ceiling value of $5,814.84 and an ultimate completion date of January 8, 2025. It is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award is for the delivery of VARIVAX vaccine with diluents to the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD). The award was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on a firm-fixed-price basis for a ceiling value of $94,114.00. The contract has an ultimate completion date of September 18, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FEXL7
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, awarded by the Defense Logistics Agency (DLA), is for the delivery of the VARIVAX vaccine with diluents. The contract has a ceiling value of $18,740.20 and a period of performance through July 10, 2024. This is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This contract does not have a set-aside designation.

Generated 9/16/24, 10:34 AM